Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2017 Aug 19

PMID 28820374

Citations 15

Authors

Marion Vermeulen

Ronel Swanevelder

Dhuly Chowdhury

Charlotte Ingram

Ravi Reddy

Evan M Bloch

Brian S Custer

Edward L Murphy

Affiliations

Soon will be listed here.

Abstract

Among 397,640 first-time blood donors screened in South Africa during 2012-2015, HIV prevalence was 1.13%, hepatitis B virus prevalence 0.66%, and hepatitis C virus prevalence 0.03%. Findings of note were a high HIV prevalence in Mpumalanga Province and the near absence of hepatitis C virus nationwide.

Citing Articles

Seroprevalence and risk factors of hepatitis B, C and D virus infection amongst patients with features of hepatitis in a referral hospital in Botswana: A cross-sectional study.

Souda S, Mwita J, Cainelli F, Mannathoko N, Anderson M, Moyo S S Afr J Infect Dis. 2024; 36(1):275.

PMID: 39372168 PMC: 11451164. DOI: 10.4102/sajid.v36i1.275.

The prevalence of hepatitis B virus, human T-lymphotropic virus and human immunodeficiency virus in patients receiving blood transfusions in South Africa.

Willemse R, Grobler C, Murphy E, Roubinian N, Colemen C, Machaba S Vox Sang. 2024; 119(11):1166-1173.

PMID: 39260452 PMC: 11826445. DOI: 10.1111/vox.13735.

Use of routinely collected blood donation data for expanded HIV and Syphilis surveillance in Blantyre district, Malawi.

Singogo E, Hartney T, Bourdin S, Chagomerana M, Kudowa E, Puerto-Meredith S PLoS One. 2024; 19(8):e0300647.

PMID: 39186758 PMC: 11346923. DOI: 10.1371/journal.pone.0300647.

Seroprevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Blood Donors in Sidi Bel Abbes, West Algeria.

Belkacemi M, Merbouh M Cureus. 2023; 15(10):e47066.

PMID: 38022198 PMC: 10644989. DOI: 10.7759/cureus.47066.

Prevalence and incidence of transfusion-transmissible infections among blood donors in Malawi: A population-level study.

Singogo E, Chagomerana M, Van Ryn C, Mbwana R, Likaka A, Mbaya B Transfus Med. 2023; 33(6):483-496.

PMID: 37828838 PMC: 11096640. DOI: 10.1111/tme.13006.

References

Tucker T, Voigt M, Bird A, Robson S, Gibbs B, Kannemeyer J . Hepatitis C virus infection rate in volunteer blood donors from the Western Cape--comparison of screening tests and PCR. S Afr Med J. 1997; 87(5):603-5. View

Amponsah-Dacosta E, Lebelo R, Rakgole J, Burnett R, Selabe S, Mphahlele M . Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa. J Med Virol. 2014; 86(6):918-24. DOI: 10.1002/jmv.23910. View

Rao V, Johari N, du Cros P, Messina J, Ford N, Cooke G . Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2015; 15(7):819-24. DOI: 10.1016/S1473-3099(15)00006-7. View

Apata I, Averhoff F, Pitman J, Bjork A, Yu J, Amin N . Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection--sub-Saharan Africa, 2000-2011. MMWR Morb Mortal Wkly Rep. 2014; 63(29):613-9. PMC: 5779426. View

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L . Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion. 2009; 49(6):1115-25. DOI: 10.1111/j.1537-2995.2009.02110.x. View

Zuma K, Shisana O, Rehle T, Simbayi L, Jooste S, Zungu N . New insights into HIV epidemic in South Africa: key findings from the National HIV Prevalence, Incidence and Behaviour Survey, 2012. Afr J AIDS Res. 2016; 15(1):67-75. DOI: 10.2989/16085906.2016.1153491. View

Rehle T, Johnson L, Hallett T, Mahy M, Kim A, Odido H . A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods. PLoS One. 2015; 10(7):e0133255. PMC: 4521952. DOI: 10.1371/journal.pone.0133255. View

Bloch E, Vermeulen M, Murphy E . Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev. 2011; 26(2):164-80. PMC: 3668661. DOI: 10.1016/j.tmrv.2011.07.006. View

Bruhn R, Lelie N, Custer B, Busch M, Kleinman S . Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios. Transfusion. 2013; 53(10 Pt 2):2399-412. DOI: 10.1111/trf.12299. View

10.

Eaton J, Bacaer N, Bershteyn A, Cambiano V, Cori A, Dorrington R . Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era. Lancet Glob Health. 2015; 3(10):e598-608. DOI: 10.1016/S2214-109X(15)00080-7. View

11.

Johnson L, Rehle T, Jooste S, Bekker L . Rates of HIV testing and diagnosis in South Africa: successes and challenges. AIDS. 2015; 29(11):1401-9. DOI: 10.1097/QAD.0000000000000721. View

12.

Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H . Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014; 61(1 Suppl):S45-57. DOI: 10.1016/j.jhep.2014.07.027. View

13.

Custer B, Kessler D, Vahidnia F, Leparc G, Krysztof D, Shaz B . Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion. 2014; 55(5):1098-107. PMC: 4428964. DOI: 10.1111/trf.12951. View

14.

Mohd Hanafiah K, Groeger J, Flaxman A, Wiersma S . Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2012; 57(4):1333-42. DOI: 10.1002/hep.26141. View